Chargement en cours...
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
BACKGROUND AND OBJECTIVES: All randomized trials of direct oral anticoagulants in atrial fibrillation excluded patients with severe kidney disease. The safety and effectiveness of direct oral anticoagulants across the range of eGFR in real-world settings is unknown. Our objective is to quantify the...
Enregistré dans:
| Publié dans: | Clin J Am Soc Nephrol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6086708/ https://ncbi.nlm.nih.gov/pubmed/30002224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.13811217 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|